| Identification | Back Directory | [Name]
Enzalutamide Carboxylic Acid Metabolite (M1) | [CAS]
1242137-15-0 | [Synonyms]
181240
Enzalutamide M1
Desmethyl-enzalutamide
Enzalutamide Impurity M
Enzalutamide Impurity 1
Enzalutamide impurity A
Enzalutamide Carboxylic acid
Enzalutamide Carboxylic Acid Metabolite
Enzalutamide Carboxylic Acid Metabolite (M1)
4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluorobenzoic acid
Benzoic acid, 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-
2-fluoro-4-(3-(4-isocyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)benzoic acid | [Molecular Formula]
C20H13F4N3O3S | [MDL Number]
MFCD28411442 | [MOL File]
1242137-15-0.mol | [Molecular Weight]
451.39 |
| Chemical Properties | Back Directory | [Melting point ]
210-212°C | [Boiling point ]
590.2±60.0 °C(Predicted) | [density ]
1.59±0.1 g/cm3(Predicted) | [storage temp. ]
Sealed in dry,2-8°C | [solubility ]
DMSO (Sparingly), Ethyl Acetate (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
2.94±0.10(Predicted) | [color ]
White | [Stability:]
Light Sensitive |
| Hazard Information | Back Directory | [Uses]
Enzalutamide Carboxylic Acid is used as hormone therapies to prevent androgen-fuled growth of castrate-resistant prostate cancer. |
|
|